EMvision Research Notes, page-918

Thanks Vintage and others for your balanced and informative posts. You are generous with your time and work.

I have been investing since Noah was a baby and I consider EMV a rare gem. However I have not seen any share price forecast so I thought I would post my simple price forecast when EMV is in production in a few years (2023??). Assuming of course the technology continues to impress.

Scanners or equivalent sold per year. -- 5000. (This is 3.5% of the western world market. Probably low but lets be prudent)
Price per scanner. ---$100,000. (Ron has mentioned $150,000 but lets be prudent)
Profit margin after tax. -- 19%. (This is similar to or lower than COH, RMD, FPH, and CSL)

These numbers when multiplied give a profit per year of $95 million. There are now 70.7 million shares on issue. Adding existing options and performance rights gives 86.8 million shares. Assuming 8.2 million shares are placed to raise funs for production gives a total issued shares of 95 million.

So $95 million profit with 95 million shares gives an earnings per share of $1.

Assuming a Price Earning Ratio of 25 (low compared to COH, CSL, RMD, FPH) gives a forecast share price of $25.

It could be a lot higher as the years go by and we develop scanners for liver and other organs.